IQVIA partners with AZ on COVID-19 vaccine clinical trials
The two companies will work to set up clinical trials utilizing IQVIA’s Virtual Trial solutions.
The two companies will work to set up clinical trials utilizing IQVIA’s Virtual Trial solutions.
The biotech provides more detail on Phase I study of its COVID-19 vaccine and agrees commercial fill-finish manufacturing.